Evidence map›Paper›PMID 22951841›Full record

ArticleJournal of virology2012

Reversible inhibition of fusion activity of a paramyxovirus fusion protein by an engineered disulfide bond in the membrane-proximal external region.

Aarohi Zokarkar, Sarah A Connolly, Theodore S Jardetzky, Robert A Lamb

Abstract read
In one paragraph

Article in Journal of virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  7. Article
  8. Article
  9. Unity in diversity: shared mechanism of entry among paramyxoviruses.Progress in molecular biology and translational science · 2015
    Review
  10. Efficient replication of a paramyxovirus independent of full zippering of the fusion protein six-helix bundle domain.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aarohi ZokarkarDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois, USA.
Sarah A Connolly
Theodore S Jardetzky
Robert A Lamb

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
STRUCTURAL STUDIES OF PARAMYXOVIRUS FUSION PROTEINSR01GM061050 · NIGMS · STANFORD UNIVERSITY · PI JARDETZKY, THEODORE S · 2000 to 2015
$3.1M
STRUCTURE &EXPRESSION OF THE PARAMYXOVIRUS SV5 GENOMER01AI023173 · NIAID · NORTHWESTERN UNIVERSITY · PI LAMB, ROBERT A · 1986 to 2010
$3.1M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA060553NIAID NIH HHS AI-23173NIAID NIH HHS R01 AI023173NIGMS NIH HHS GM-61050NIGMS NIH HHS R01 GM061050
6 · The paper itself

Abstract

Cysteines were introduced into the membrane-proximal external region (MPER) of the paramyxovirus F protein. A disulfide bond formed, and the mutant protein was expressed at the cell surface but was fusion inactive. Reduction of the disulfide bond restored fusion activity. The data indicate that in addition to dissociation of the three-helix bundle stalk domain of prefusion F, the MPER region also needs to separate for F to be able to refold and cause fusion.

Indexed as

Cell MembraneCysteineDisulfidesHeLa CellsHumansMembrane FusionModels, MolecularMutationProtein BindingProtein FoldingProtein Structure, TertiaryTissue EngineeringViral Fusion ProteinsViral ProteinsCysteineDisulfidesViral Fusion ProteinsViral Proteins

Identifiers

PMID22951841
PMCPMC3486459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.